✦ LIBER ✦

PMS34 AN EXPLORATORY EVALUATION OF THE COST-EFFECTIVENESS OF RITUXIMAB AND ABATACEPT IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO A TUMOUR NECROSIS FACTOR INHIBITOR IN CANADA

✍ Scribed by S Yunger; B Mistry

Book ID: 118611008
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 88 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)73410-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Longterm Safety and Efficacy of Abatacep

Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy

✍ GENOVESE, M. C.; SCHIFF, M.; LUGGEN, M.; LE BARS, M.; ARANDA, R.; ELEGBE, A.; DO 📂 Article 📅 2012 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 504 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS46 Cost-Utility Analysis of Certolizu

PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Spain

✍ R. Villoro; A. Hidalgo; B. Ferro; P. Talavera 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

BL1 COST-EFFECTIVENESS, VALUE OF INFORMA

BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND

✍ EJ Soini; T Hallinen; M Taiha; V Honkanen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Indirect comparisons of the efficacy of

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

✍ Salliot, C.; Finckh, A.; Katchamart, W.; Lu, Y.; Sun, Y.; Bombardier, C.; Keysto 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 299 KB